10X Genomics Inc
NASDAQ:TXG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
10X Genomics Inc (TXG) under the Base Case is 18.88 USD per share.
Compared with the current market price of 59.28 USD, the stock appears
Overvalued by 68% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -15% last year to 1% by 2031. If operating margin stayed at its five-year average of -24%, the estimate would be about $15. The value of the years after 2031 is tied to revenue, so margins count only until then.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What 10X Genomics Does
10X Genomics makes tools that help scientists study biology at a much finer level than older lab methods. Its main products are instruments, chemical kits, and software used to analyze single cells and tissue samples, so researchers can see which genes are active in individual cells and where those cells sit inside a tissue.
- Headquarters
- United States of America US
- Employees
- 1 178
- IPO date
- Sep 12, 2019
10X Genomics has no economic moat
Researchers can choose among competing tools for single-cell and spatial analysis, and 10x’s products do not become more useful simply because more labs use them. Its products serve contested research markets where labs have alternatives and new suppliers can enter.
Read the full moat analysis
Revenue & Expenses Breakdown
10X Genomics Inc
Earnings Waterfall
10X Genomics Inc
What is the Intrinsic Value of one TXG stock?
The intrinsic value for 10X Genomics Inc (TXG) under the Base Case is 18.88 USD.
Is TXG stock undervalued or overvalued?
Compared with the current market price of 59.28 USD, the stock appears Overvalued by 68% .
